Form 8-K - Current report:
SEC Accession No. 0000950170-24-135823
Filing Date
2024-12-12
Accepted
2024-12-12 16:30:19
Documents
63
Period of Report
2024-12-12
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K clsd-20241212.htm   iXBRL 8-K 45597
2 EX-99.1 clsd-ex99_1.htm EX-99.1 50922
3 GRAPHIC clsd-ex99_1s1.jpg GRAPHIC 423864
4 GRAPHIC clsd-ex99_1s2.jpg GRAPHIC 752208
5 GRAPHIC clsd-ex99_1s3.jpg GRAPHIC 317620
6 GRAPHIC clsd-ex99_1s4.jpg GRAPHIC 485768
7 GRAPHIC clsd-ex99_1s5.jpg GRAPHIC 420007
8 GRAPHIC clsd-ex99_1s6.jpg GRAPHIC 341838
9 GRAPHIC clsd-ex99_1s7.jpg GRAPHIC 282235
10 GRAPHIC clsd-ex99_1s8.jpg GRAPHIC 379106
11 GRAPHIC clsd-ex99_1s9.jpg GRAPHIC 251521
12 GRAPHIC clsd-ex99_1s10.jpg GRAPHIC 299340
13 GRAPHIC clsd-ex99_1s11.jpg GRAPHIC 351760
14 GRAPHIC clsd-ex99_1s12.jpg GRAPHIC 321074
15 GRAPHIC clsd-ex99_1s13.jpg GRAPHIC 349020
16 GRAPHIC clsd-ex99_1s14.jpg GRAPHIC 394379
17 GRAPHIC clsd-ex99_1s15.jpg GRAPHIC 509556
18 GRAPHIC clsd-ex99_1s16.jpg GRAPHIC 250891
19 GRAPHIC clsd-ex99_1s17.jpg GRAPHIC 372124
20 GRAPHIC clsd-ex99_1s18.jpg GRAPHIC 426116
21 GRAPHIC clsd-ex99_1s19.jpg GRAPHIC 145080
22 GRAPHIC clsd-ex99_1s20.jpg GRAPHIC 280016
23 GRAPHIC clsd-ex99_1s21.jpg GRAPHIC 347493
24 GRAPHIC clsd-ex99_1s22.jpg GRAPHIC 372603
25 GRAPHIC clsd-ex99_1s23.jpg GRAPHIC 514709
26 GRAPHIC clsd-ex99_1s24.jpg GRAPHIC 349590
27 GRAPHIC clsd-ex99_1s25.jpg GRAPHIC 275126
28 GRAPHIC clsd-ex99_1s26.jpg GRAPHIC 300033
29 GRAPHIC clsd-ex99_1s27.jpg GRAPHIC 287629
30 GRAPHIC clsd-ex99_1s28.jpg GRAPHIC 316665
31 GRAPHIC clsd-ex99_1s29.jpg GRAPHIC 350716
32 GRAPHIC clsd-ex99_1s30.jpg GRAPHIC 286305
33 GRAPHIC clsd-ex99_1s31.jpg GRAPHIC 365651
34 GRAPHIC clsd-ex99_1s32.jpg GRAPHIC 302920
35 GRAPHIC clsd-ex99_1s33.jpg GRAPHIC 424203
36 GRAPHIC clsd-ex99_1s34.jpg GRAPHIC 390189
37 GRAPHIC clsd-ex99_1s35.jpg GRAPHIC 471789
38 GRAPHIC clsd-ex99_1s36.jpg GRAPHIC 303704
39 GRAPHIC clsd-ex99_1s37.jpg GRAPHIC 386833
40 GRAPHIC clsd-ex99_1s38.jpg GRAPHIC 384048
41 GRAPHIC clsd-ex99_1s39.jpg GRAPHIC 358219
42 GRAPHIC clsd-ex99_1s40.jpg GRAPHIC 455130
43 GRAPHIC clsd-ex99_1s41.jpg GRAPHIC 308156
44 GRAPHIC clsd-ex99_1s42.jpg GRAPHIC 334548
45 GRAPHIC clsd-ex99_1s43.jpg GRAPHIC 519974
46 GRAPHIC clsd-ex99_1s44.jpg GRAPHIC 330758
47 GRAPHIC clsd-ex99_1s45.jpg GRAPHIC 355066
48 GRAPHIC clsd-ex99_1s46.jpg GRAPHIC 377961
49 GRAPHIC clsd-ex99_1s47.jpg GRAPHIC 332068
50 GRAPHIC clsd-ex99_1s48.jpg GRAPHIC 433347
51 GRAPHIC clsd-ex99_1s49.jpg GRAPHIC 331052
52 GRAPHIC clsd-ex99_1s50.jpg GRAPHIC 346314
53 GRAPHIC clsd-ex99_1s51.jpg GRAPHIC 270012
  Complete submission text file 0000950170-24-135823.txt   25752423

Data Files

Seq Description Document Type Size
54 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT clsd-20241212.xsd EX-101.SCH 24862
65 EXTRACTED XBRL INSTANCE DOCUMENT clsd-20241212_htm.xml XML 4719
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 241545280
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)